Beta-adrenoceptor activity change after prolonged treatment with growth hormone and somatostatin.
1. The effect of 10 days treatment with growth hormone (GH) (1 mg/kg body wt/day) and somatostatin (SRIF) (0.25 mg/kg body wt/day) subcutaneously on the activity of beta-adrenoceptors in rat hypothalamic, pituitary and cerebral cortical membrane fractions was studied using [3H]dihydroalprenolol ([3H]DHA) as radioligand. 2. The administration of GH significantly increased the beta-adrenoceptor binding affinity and the administration of SRIF decreased the beta-adrenoceptor binding capacity in the hypothalamus. 3. In the pituitary the beta-adrenoceptor binding affinity was significantly decreased after both hormonal applications. 4. In the cerebral cortex the beta-adrenoceptor binding affinity was significantly decreased after the GH treatment and increased after the SRIF treatment. 5. The present study provides direct evidence for GH and SRIF effects on the activity of rat beta-adrenoceptors and supports the view about the involvement of beta-adrenergic mechanisms in the neurotransmitter regulation of GH secretion in the rat.
Popova
J
J
Institute of Endocrinology and Gerontology, Bulgarian Medical Academy, Sofia.
Robeva
A
A
Iavorska
N
N
Zaharieva
S
S
D000818:Animals; D002540:Cerebral Cortex / Q000502:physiology*; D013006:Growth Hormone / Q000502:physiology*; D007031:Hypothalamus / Q000502:physiology*; D008297:Male; D010902:Pituitary Gland / Q000502:physiology*; D051381:Rats; D011919:Rats, Inbred Strains; D011943:Receptors, Adrenergic, beta / Q000378:metabolism / Q000502:physiology*; D013004:Somatostatin / Q000502:physiology*; D013997:Time Factors
D011943:Receptors, Adrenergic, beta; D013004:Somatostatin; D013006:Growth Hormone